Evidence map›Paper›PMID 37577508›Full record

ArticlebioRxiv : the preprint server for biology2025

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis.

Nikol Kadeřábková, R Christopher D Furniss, Evgenia Maslova, Kathryn E Potter, Lara Eisaiankhongi, Patricia Bernal, Alain Filloux, Cristina Landeta, Diego Gonzalez, Ronan R McCarthy and 1 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Nikol KadeřábkováDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, 78712, Texas, USA.
R Christopher D FurnissCentre for Bacterial Resistance Biology, Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
Evgenia MaslovaDivision of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.
Kathryn E PotterDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, 78712, Texas, USA.
Lara EisaiankhongiDivision of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.
Patricia BernalDepartamento de Microbiología, Facultad de Biología, Universidad de Sevilla, Seville, 41012, Spain.
Alain FillouxCentre for Bacterial Resistance Biology, Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
Cristina LandetaDepartment of Biology, Indiana University, Bloomington, Indiana, 47405, USA.
Diego GonzalezLaboratoire de Microbiologie, Institut de Biologie, Université de Neuchâtel, Neuchâtel, 2000, Switzerland.
Ronan R McCarthyDivision of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.ORCID 0000-0002-7480-6352
Despoina A I MavridouDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, 78712, Texas, USA.
Brunel University of London · GBImperial College London · GBNanyang Technological University · SGIndiana University Bloomington · USThe University of Texas at Austin · USUniversity of Neuchâtel · CH

Funding

The interplay between cell envelope protein homeostasis and antibiotic resistance in Gram-negative bacteriaR01AI158753 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI Despoina Mavridou · 2022 to 2026
$1.9M
NIAID NIH HHS R01 AI158753Wellcome Trust
6 · The paper itself

Abstract

Critical Gram-negative pathogens, like

Indexed as

antibiotic potentiationantimicrobial resistancecross-resistancecystic fibrosisGram-negative bacterial pathogenspolymicrobial communitiesprotein homeostasis

Identifiers

PMID37577508
PMCPMC10418187
OpenAlexW4385551736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.